Hints and tips:
...Prof Katyal fought to overturn the patents held by Myriad Genetics that could help diagnose breast cancer, winning a unanimous Supreme Court decision....
...The immediate target of their wrath is the gene patents held by Myriad Corporation over the BRCA1 and BRCA2 genes that have been implicated in breast cancer....
...Stiles’s superbly written book argues that the main legacy of the “robber baron” and “railroad king” was the giant but invisible corporation, so big that it was able to crush its competitors....
...Myriad Genetics also rose, finishing 0.2 per cent up at $18.27 on the back of a Merrill Lynch upgrade....
International Edition